TRP 'scam': Ex-BARC CEO Partho Dasgupta hospitalised in Mumbai after blood sugar levels shoot up

-

Mumbai: Partho Dasgupta, a former CEO of TV ratings agency BARC who was arrested in the Television Rating Points (TRP) rigging case, has been admitted to the ICU of a hospital here after his sugar level shot up, officials said on Saturday.

His daughter took to Twitter to allege that he was tortured in prison, and appealed to Prime Minister Narendra Modi and others to `save his life'.

Dasgupta, 55, a diabetic, was rushed to the state-run JJ Hospital from the Taloja Central Prison in Navi Mumbai around midnight after his blood sugar levels shot up, a prison official said.

He was admitted to the ICU and was on oxygen support, the official said.

Dasgupta, former CEO of Broadcast Audience Research Council (BARC) was arrested in the alleged TRP rigging scam by the crime branch of the Mumbai Police on 24 December last year.

A Mumbai court had earlier this month rejected his bail plea, stating that he appeared to have played a vital role in the scam to rig TRP as per the police's case.

The Mumbai Police had earlier told the court that Republic TV Editor-in-Chief Arnab Goswami had allegedly bribed Dasgupta with "lakhs of rupees" to ramp up the news channel's viewership numbers fraudulently.

On Saturday, Pratyusha Dasgupta, Dasgupta's daughter, demanded that he be shifted to a reputed private hospital.

She tweeted a message titled "A helpless daughter's anguished appeal", tagging PM Modi, Union home minister Amit Shah, the PMO as well as Maharashtra chief minister Uddhav Thackeray.

Her mother received a call around 3 am on Saturday informing that her father had been brought to the hospital in the unconscious state around 1 pm on Friday, she said.

For 14 hours nobody from the family was informed about Dasgupta's condition because the authorities allegedly did not

have their contact numbers, Pratyusha said.

When they reached the hospital, they found he was unable to speak, she said.

It was apparent that he had been "physically and mentally tortured inside the jail", she alleged.

Prison officials were not available for giving reaction on her allegations.



from Firstpost India Latest News https://ift.tt/2Kn1bed
Press Trust of India

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more